Polysaccharides: A targeting strategy for colonic drug delivery

Expert Opinion on Drug Delivery

Volumn 8, Issue 6, 2011, Pages 779-796

  Shah, Nitesh ^a   Shah, Tejal ^a   Amin, Avani ^a  

^a NIRMA UNIVERSITY   (India)

Author keywords

compression coated; hydrogel; physiological conditions; polysaccharides; transit time

Indexed keywords

ALGAROBA; ALGINIC ACID; AMYLIN; AMYLOSE; ANTISENSE OLIGONUCLEOTIDE; CALCITONIN; CHITOSAN; CHONDROITIN SULFATE; CYCLOSPORIN A; DESMOPRESSIN; DEXTRAN; EPOEITIN; ETANERCEPT; GLUCAGON; GONADORELIN; GUAR GUM; HUMAN GROWTH HORMONE; INSULIN; INTERFERON; INULIN; LEUPRORELIN; OCTREOTIDE; PECTIN; POLYSACCHARIDE; PRODRUG; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; SALCATONIN; SERMORELIN; UNCLASSIFIED DRUG; UROFOLLITIN; VASOPRESSIN;

AMIDATION; CARBOHYDRATE ANALYSIS; DEGRADATION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG TARGETING; DRUG USE; ESTERIFICATION; HUMAN; NONHUMAN; REVIEW;

ADMINISTRATION, ORAL; ANIMALS; COLON; COLONIC DISEASES; DRUG CARRIERS; DRUG COMPOUNDING; HUMANS; INTESTINAL ABSORPTION; MOLECULAR STRUCTURE; POLYSACCHARIDES; TABLETS, ENTERIC-COATED;

EID: 79956221113     PISSN: 17425247     EISSN: 17447593     Source Type: Journal    
DOI: 10.1517/17425247.2011.574121     Document Type: Review

References (98)

1. Patel M, Shah T, Amin A.Therapeutic opportunities in colon-specific drug-delivery systems.Crit Rev Ther Drug Carrier Syst 2007;24:147-202 (Pubitemid 47324847)
2. Chourasia MK, Jain SK.Pharmaceutical approaches to colon targeted drug delivery systems.J Pharm Pharm Sci 2003;6(6):33-66 (Pubitemid 37207241)
3. Zhou HW.Overcoming enzymatic and absorption barriers to non-parenterally administered protein and peptide drugs.J Control Release 1994;29:239-52
4. Loftus EV, Silverstein MD, Sandborn WJ, et al.Ulcerative colitis in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival.Gut 2000;46:336-43 (Pubitemid 30313384)
5. Loftus EV, Silverstein MD, Sandborn WJ, et al.Crohn's disease in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. Gastroenterology 1998;114:1161-8
6. Edwards C.Physiology of the colorectal barrier.Adv Drug Deliv Rev 1997;28:173-90 (Pubitemid 28078665)
7. Watts PJ, Illum L.Colonic drug delivery.Drug Dev Ind Pharm 1997;23(9):893-913 (Pubitemid 27406363)
8. Rubinstein A.Approaches and opportunities in colon specific drug delivery.Crit Rev Ther Drug Carrier Syst 1995;12(2-3):101-49
9. Ashford M, Fell JT.Targeting drugs to the colon: delivery systems for oral administration.J Drug Target 1994;2:241-58
10. Camma C, Giunta M, Rosselli M, Cottone M.Mesalamine in the maintenance treatment of Crohn's disease: a meta-analysis adjusted for confounding variables.Gastroenterology 1997;113:1465-73 (Pubitemid 27461232)
11. Ewe K, Schwartz S, Petersen S, Press AG.Inflammation does not decrease intraluminal pH in chronic inflammatory bowel disease.Dig Dis Sci 1999;44:1434-9 (Pubitemid 29404310)
12. Kaus LC, Fell JT, Sharma H, Taylor DC.On the intestinal transit of a single non-disintegrating object.Int J Pharm 1984;14:143-8
13. Rubinstein A.Natural polysaccharides as targeting tools of drugs to the human colon.Drug Dev Res 2000;50:435-9
14. Yang L, Chu JS, Fix JA.Colon-specific drug delivery: new approaches and in vitro/in vivo evaluation.Int J Pharm 2002;235:1-15 (Pubitemid 34185432)
15. Moore WEC, Holdeman LV.Discussion of current bacteriological investigations of the relationship between intestinal flora, diet and colon cancer.Cancer Res 1975;35:3418-20
16. Cummings JH, Englyst HN.Fermentation in the human large intestine and available substrates.Am J Clin Nutr 1987;45:1243-7
17. Levitt MD, Hirsh P, Fetzer CA, et al.H2 excretion after ingestion of complex carbohydrates.Gastroenterology 1987;92:383-6
18. Van Soest PJ.Dietary fibers: their definition and nutritional properties.Am J Clin Nutr 1978;31:10S12-20
19. Kinget R, Kalala W, Vervoort L, Mooter GU.Colonic drug targeting.J Drug Target 1998;6:129-49 (Pubitemid 29033981)
20. Scheline RR.Metabolism of foreign compounds by gastrointestinal microorganisms.Pharmacol Res 1973;25:451-523
21. Philip AK, Philip B.Colon targeted drug delivery systems: a review on primary and novel approaches.Oman Medical J 2010;25:70-8
22. Salyers AA.Energy sources of major intestinal fermentative anaerobes.Am J Clin Nutr 1979;32:158-63
23. Salyers AA, Brien M.Cellular location of enzymes involved in chondroitin sulfate breakdown by Bacteroides thetaiotaomicron.J Bacteriol 1980;143:772-80 (Pubitemid 10017648)
24. Salyers AA, Vercellotti JR, West SHE, Wilkins TD.Fermentation of mucin and plant polysaccharides by strains of Bacteroides from the human colon.Appl Environ Microbiol 1977;33:319-22 (Pubitemid 8099781)
25. Rubinstein R, Radai M, Ezra S, et al.In vitro evaluation of calcium pectinate: a potential colon-specific drug delivery carrier.Pharm Res 1993;10:258-63
26. Ashford M, Fell JT, Attwood D, et al.Studies on pectin formulation for colonic drug delivery.J Control Release 1994;30:225-32
27. Chourasia MK, Jain SK.Polysaccharides for colon targeted drug delivery.Drug Deliv 2004;11:129-48 (Pubitemid 38437082)
28. Sriamornsak P.Investigation of pectin as a carrier for oral delivery of proteins using calcium pectinate gel beads.Int J Pharm 1998;169:213-20 (Pubitemid 28345257)
29. Das S, Ka-Yun NG.Impact of glutaraldehyde on in vivo colon-specific release of resveratrol from biodegradable pectin-based formulation.J Pharm Sci 2010;99(12):4903-16
30. Bhalla HL, Shah AA.Controlled release matrices for ketoprofen.Ind Drugs 1991;28:420-2
31. Brosio A, Dubaldo A, Verzegnassi B.Pulsed field gradient spin-echo NMR measurement of water diffusion coefficient in thickening and gelling agents: guar galactomannan solutions and pectin gels.Cell Mol Biol 1994;40:569-73
32. Gliko-Kabir I, Yagen B, Baluom M, Rubinstein A.Phosphated crosslinked guar for colon-specific drug delivery.II.In vitro and in vivo evaluation in the rat.J Control Release 2000;63(1-2):129-34 (Pubitemid 30046948)
33. Payne GF, Chaubal MV, Barbari T.Enzyme-catalyzed polymer modification: reaction of phenolic compounds with chitosan films.Polymer (Guildf) 1996;37:4643-8 (Pubitemid 126382285)
34. Lorenzo-Lamosa ML, Remunan-Lopez C, Vila-Jato JL, Alonso MJ.Design of microencapsulated chitosan microspheres for colonic drug delivery.J Control Release 1998;52:109-18 (Pubitemid 28123178)
35. Risbud MV, Hardikar AA, Sujata V, et al.pH sensitive freeze-dried chitosan-polyvinyl pyrrolidone hydrogels as controlled release system for antibiotic delivery.J Control Release 2000;68(1):23-30 (Pubitemid 30407059)
36. Yassin AE, Dallia AR, Kassem AE.Comparative bioavailability of two tablet formulations of metronidazole in human volunteers: an assessment of colonic targeting.Egypt J Biomed Sci 2003;12:40-8
37. Basit AW.Oral colon-specific drug delivery using amylose-based film coatings.Pharm Technol Eur 2000;12:30-6
38. Ellis HS, Ring SG.A study of some factors influencing amylose gelation.Carbohydr Polym 1985;5:201-3
39. Roberfroid MB Introducing inulin-type fructans.Br J Nutr 2005;93(1):S13-25
40. McKellar RC, Modler HW Metabolism of fructooligosaccharides by Bifidobacterium spp.Appl Microbiol Biotechnol 1989;31:537-41
41. Vervoort L, Vinckier I, Moldenaers P, et al.Inulin hydrogels as carriers for colonic drug targeting.Rheological characterization of the hydrogel formation and the hydrogel network.J Pharm Sci 1999;88(2):209-14 (Pubitemid 29084733)
42. Sinha VR, Kumria R.Polysaccharides in colon-specific drug delivery.Int J Pharm 2001;224:19-38 (Pubitemid 32706482)
43. Bauer KH, Kesselhut JF.Novel pharmaceutical excipients for colon targeting.STP Pharm Sci 1995;5:54-9
44. Salyers AA, Vercellotti JR, West SHE, Wilkins TD.Fermentation of mucin and plant polysaccharides by strains of Bacteroides from the human colon.Appl Environ Microbiol 1977;33:319-22 (Pubitemid 8099781)
45. Rubinstein A, Nakar D, Sintov A.Chondroitin sulphate: a potential biodegradable carrier for colon-specific drug delivery.Int J Pharm 1992;84:141-50
46. Sintov A, Di-capua N, Rubinstein A.Cross-linked chondroitin sulphate: characterization for drug delivery purposes.Biomaterials 1995;16:473-8
47. Sery TW, Hehre EJ.Degradation of dextrans by enzymes of intestinal bacteria.J Bacteriol 1956;71:373-80
48. Varshosaz J, Ahmadi F, Emami J, et al.Colon delivery of budesonide using solid dispersion in dextran for the treatment and secondary prevention of ulcerative colitis in rat.Int J Prev Med 2010;1(2):116-24
49. Bauer KH, Kesselhut JF.Novel pharmaceutical excipients for colon targeting.STP Pharm Sci 1995;5:54-9
50. Hirsch S, Binder V, Kolter K, et al.Lauroyldextran as a coating material for site-specific drug delivery to the colon: in-vitro dissolution of coated tablets.Proc Int Symp Control Rel Bioact Mater 1997;24:379-80 (Pubitemid 27336567)
51. Hirsch S, Binder V, Schehlmann V, et al.Lauroyldextran and cross-linked galactomannan as coating materials for site-specific drug delivery to the colon.Eur J Pharm Biopharm 1999;47:61-71 (Pubitemid 29137757)
52. Grant GT, Morris ER, Rees DA, et al.Biological interactions between polysaccharides and divalent cations: the egg box model.FEBS Lett 1973;32:195-8
53. Pillay V, Danckwerts MP, Fassihi R.A crosslinked calcium-alginate- pectinatecellulose acetophthalate gelisphere system for linear drug release.Drug Deliv 2002;9(2):77-86 (Pubitemid 34606531)
54. Kim CK, Lee EJ.The controlled release of blue dextran from alginate beads.Int J Pharm 1992;79:11-19
55. Kulkarni AR, Soppimath KS, Aminabhavi TM, Dave AM.Polymeric sodium alginate interpenetrating network beads for the controlled release of chlorpyrifos.J Appl Polym Sci 2002;85(5):911-18 (Pubitemid 34638666)
56. Xi MM, Zhang SQ, Wang XY, et al.Study on the characteristics of pectin-ketoprofen for colon targeting in rats.Int J Pharm 2005;298(1):91-7
57. Van den MG, Vervoort L, Kinget R.Characterization of methacrylated inulin hydrogels designed for colon targeting: in vitro release of BSA.Pharm Res 2003;20(2):303-7 (Pubitemid 36269740)
58. Maris B, Verheyden L, Van Reeth K, et al.Synthesis and characterization of inulin-azo hydrogels designed for colon targeting.Int J Pharm 2001;213(1-2):143-52 (Pubitemid 32119470)
59. Larsen C, Jensen BH, Olesen HP.Bioavailability of ketoprofen from orally administered ketoprofen-dextran ester prodrug in the pig.Acta Pharm Nord 1991;3:71-6
60. Harboe E, Larsen C, Johansen M, Olesen HP.Macromolecular prodrugs.XV.Colon targeted delivery - bioavailability of naproxen from orally administered dextran-naproxen ester prodrugs varying in molecular size in the pig.Pharm Res 1989;6:919-23 (Pubitemid 20078440)
61. McLeod AD, Friend DR, Tozer TN.Glucocorticoid-dextran conjugates as potential prodrugs for colon-specific delivery: hydrolysis in rat gastrointestinal tract contents.J Pharm Sci 1994;83:1284-8 (Pubitemid 24282335)
62. Varshosaz J, Emami J, Fassihi A, et al.Effectiveness of budesonide-succinatedextran conjugate as a novel prodrug of budesonide against acetic acid-induced colitis in rats.Int J Colorectal Dis 2010;25:1159-65
63. Tozaki H, Fujita T, Odoriba T, et al.Colon, a specific delivery of R68070 new thromboxane synthase inhibitor, using chitosan capsules: therapeutic effects against 2,4,6-trinitrobenzene sulfonic acid induced ulcerative colitis in rats.Life Sci 1999;64:1155-62 (Pubitemid 29152033)
64. Tozaki H, Odoriba T, Okada N, et al.Chitosan capsules for colonspecific drug delivery: enhanced localization of 5-aminosalicylic acid in the large intestine accelerates healing of TNBS-induced colitis in rats.J Control Release 2002;82:51-61 (Pubitemid 34775047)
65. Tozaki H, Komoike J, Tada C, et al.Chitosan capsules for colonspecific drug delivery: Improvement of insulin absorption from rat colon.J Pharm Sci 1997;86:1016-21 (Pubitemid 27382903)
66. Brondsted H, Andersen C, Hovgaard L.Cross-linked dextran - a new capsule material for colon targeting of drug.J Control Release 1998;53:7-13 (Pubitemid 28218685)
67. Tuleu C, Basit AW, Waddington WA, et al.Colonic delivery of 4-aminosalicylic acid using amylose-ethylcellulose-coated hydroxypropylmethylcellulose capsules.Aliment Pharmacol Ther 2002;16(10):1771-9
68. Rama Prasad YV, Krishnaiah YS, Satyanarayana S.In vitro evaluation of guar gum as a carrier for colon-specific drug delivery.J Control Release 1998;51:281-7 (Pubitemid 28252880)
69. Al-Saidan SM, Krishnaiah YS, Satyanarayana V, Rao GS.In vitro and in vivo evaluation of guar gum-based matrix tablets of rofecoxib for colonic drug delivery.Curr Drug Deliv 2005;2(2):155-63 (Pubitemid 40488625)
70. Krishnaiah YS, Satyanarayana V, Kumar BD, Karthikeyan RS.Studies on the development of colon-targeted delivery systems for celecoxib in the prevention of colorectal cancer.J Drug Target 2002;10(3):247-54 (Pubitemid 34467294)
71. Krishnaiah YS, Veer Raju P, Dinesh Kumar B, et al.Development of colon targeted drug delivery systems for mebendazole.J Control Release 2001;9:77(1-2):87-95 (Pubitemid 33022618)
72. Raghavan CV, Muthulingam C, Jenita JA, Ravi TK.An in vitro and in vivo investigation into the suitability of bacterially triggered delivery system for colon targeting.Chem Pharm Bull 2002;50(7):892-5 (Pubitemid 41694862)
73. Wakerly Z, Fell JT, Attwood D, Parkins D.Pectin/Ethyl cellulose film coating formualtions for colonic drug delivery.Pharm Res 1996;13(8):1210-12 (Pubitemid 26279327)
74. Wei H, Qing D, De-Ying C, et al.Pectin/Ethylcellulose as film coatings for colon-specific drug delivery: preparation and in vitro evaluation using 5-fluorouracil pellets.PDA J Pharm Sci Technol 2007;61(2):121-30 (Pubitemid 46651444)
75. Wei H, Li-Fang F, Yong-Zhen C, et al.Pectin/Kollicoat SR30D isolated films for colonic delivery: a comparison of normal and colitis-induced models to assess the efficiency of microbially triggered drug delivery.J Pharm Pharmacol 2009;61(2):167-76
76. Ji CM, Xu HN, Sun NY, et al.Guar gum/ethylcellulose coated pellets for colon-specific drug delivery.Acta pharmaceutica Sinica 2007;42(6):656-62
77. Leong CW, Newton JM, Basit AW, et al.The formation of colonic digestible films of amylose and ethylcellulose from aqueous dispersions at temperatures below 37-C.Eur J Pharm Biopharm 2002;54:291-7 (Pubitemid 35341829)
78. Wilson PJ, Basit AW.Exploiting gastrointestinal bacteria to target drugs to the colon: an in vitro study using amylose coated tablets.Int J Pharm 2005;300(1-2):89-94 (Pubitemid 41112170)
79. Milojevic S, Newton JM, Cummings JH, et al.Amylose as a coating for drug delivery to the colon: preparation and in vitro evaluation using 5-aminosalicylic acid pellets.J Control Release 1996;38:75-84 (Pubitemid 26027181)
80. Milojevic S, Newton JM, Cummings JH, et al.Amylose as a coating for drug delivery to the colon: preparation and in vitro evaluation using glucose pellets.J Control Release 1996;38:85-94 (Pubitemid 26027182)
81. Semde R, Amighi K, Devleeschouwer MJ, Moes AJ.Studies of pectin HM: Eudragit RL:Eudragit NE film-coating formulations intended for colonic drug delivery.Int J Pharm 2000;197:181-92
82. Macleod GS, Fell JT, Collett JH, et al.Selective drug delivery to the colon using pectin:chitosan:hydroxypropyl methylcellulose film coated tablets.Int J Pharm 1999;187:251-7 (Pubitemid 29443905)
83. Tominaga S, Takaizawa T, Yamada M.Colon drug delivery system.J Pol Appl 1998;JP 10:642 (98324,642) (C1 A61K47/36)
84. Rubinstein A, Radai R.In vitro and in vivo analysis of colon specificity of calcium pectinate formulations.Eur J Pharm Biopharm 1995;41:291-5
85. Patel NV, Patel JK, Shah SH.Box-Behnken.Experimental design in the development of pectin-compritol ATO 888 compression coated colon targeted drug delivery of mesalamine.Acta Pharm 2010;60:39-54
86. Krishnaiah YS, Indira Muzib Y, Srinivasa Rao G, et al.Design and in vitro evaluation of oral colon targeted drug delivery systems for tinidazole.J Drug Target 2002;Dec;10(8):579-84 (Pubitemid 36124357)
87. Krishnaiah YS, Muzib YI, Rao GS, et al.Studies on the development of colon targeted oral drug delivery systems for ornidazole in the treatment of amoebiasis.Drug Deliv 2003;10(2):111-17 (Pubitemid 36588512)
88. Krishnaiah YS, Satyanarayana V, Dinesh Kumar B, Karthikeyan RS.In vitro drug release studies on guar gum-based colon targeted oral drug delivery systems of 5-fluorouracil.Eur J Pharm Sci 2002;16(3):185-92 (Pubitemid 34786453)
89. Nunthanid J, Huanbutta K, Luangtana-anan M, et al.Development of time-, pH-, and enzyme-controlled colonic drug delivery using spray-dried chitosan acetate and hydroxypropyl methylcellulose.Eur J Pharm Biopharm 2008;68:253-9
90. Alaa-Eldeen BY, Ibrahim AA, Fars KA, et al.New targeted-colon delivery system: in vitro and in vivo evaluation using X-ray imaging.J Drug Target 2010;18(1):59-66
91. Jain A, Gupta Y, Jain SK.Potential of calcium pectinate beads for target specific drug release to colon.J Drug Target 2007;15(4):285-94 (Pubitemid 47177036)
92. Paharia A, Yadav AK, Rai G, et al.Eudragit-coated pectin microspheres of 5-fluorouracil for colon targeting.AAPS PharmSci Tech 2007;8(1):E1-7 (Pubitemid 46370363)
93. Vaidya A, Jain A, Khare P, et al.Metronidazole loaded pectin microspheres for colon targeting.J Pharm Sci 2009;98(11):4229-36
94. Jain SK, Jain A, Gupta Y, Ahirwar M.Design and development of hydrogel beads for targeted drug delivery to the colon.AAPS PharmSci Tech 2007;8(3):E1-8 (Pubitemid 47103044)
95. Chourasia MK, Jain SK.Design and development of multiparticulate system for targeted drug delivery to colon.Drug Deliv 2004;11:201-7 (Pubitemid 38720417)
96. Jose S, Dhanya K, Cinu TA, Aleykutty NA.Multiparticulate system for colon targeted delivery of Ondansetron.Ind J Pharm Sci 2010;72(1):58-64
97. Liu H, Yang XG, Nie SF, et al.Chitosan-based controlled porosity osmotic pump for colon-specific delivery system: screening of formulation variables and in vitro investigation.Int J Pharm 2007;332(1-2):115-24 (Pubitemid 46227777)
98. Pitarresi G, Casadei MA, Mandracchia D, et al.Photo crosslinking of dextran and polyaspartamide derivatives: a combination suitable for colon-specific drug delivery.J Control Release 2007;119:328-38 (Pubitemid 46770878)